Amazon Enters GLP‑1 Market
- Amazon launched a GLP‑1 weight‑loss program through Amazon Pharmacy and Amazon One Medical. (cnbc.com) - The program promises easier access to Wegovy and newer oral GLP‑1 options for consumers. (rttnews.com) - This rollout shifts GLP‑1 distribution toward mainstream retail channels and could affect access and demand. (cnbc.com)
Amazon has started selling a weight-loss program built around GLP-1 drugs, folding One Medical care and Amazon Pharmacy delivery into one service. (cnbc.com) GLP-1 drugs mimic a gut hormone that helps people feel full and slow digestion; brand names in the category include Wegovy and Zepbound. Amazon said patients can use the new program through One Medical clinicians, with prescriptions filled through Amazon Pharmacy. (health.amazon.com) (cnbc.com) The company announced the program on April 21, 2026. CNBC reported pricing starts as low as $25 a month with insurance, while Dow Jones reported cash-pay pricing of $149 a month for oral GLP-1 options and $299 a month for injectables. (cnbc.com) (morningstar.com) Amazon is pitching the service as ongoing primary care, not a one-time prescription. The company said One Medical clinicians will monitor progress, adjust treatment, and manage related conditions as patients lose weight. (morningstar.com) (beckershospitalreview.com) That puts Amazon deeper into a market that has been dominated by drugmakers, specialty obesity clinics, telehealth startups, and traditional pharmacies. Axios reported the rollout is national, and Amazon is tying it to a primary-care network it bought with the $3.9 billion One Medical acquisition in 2023. (axios.com) (reuters.com) The timing also reflects a supply picture that looks different from a year ago. Amazon’s GLP-1 help page says semaglutide and tirzepatide injection shortages have been resolved and inventory has stabilized, easing one of the biggest barriers to wider retail distribution. (amazon.com) Amazon is pairing that with faster delivery. In February, Amazon Pharmacy said it would expand same-day prescription delivery to nearly 4,500 U.S. cities and towns by the end of 2026, up by nearly 2,000 communities over the year. (press.aboutamazon.com) The move lands in a crowded field. Hims & Hers, Ro, LillyDirect, and NovoCare have all built online paths to obesity drugs, but Amazon is trying to combine prescribing, routine follow-up, insurance handling, and pharmacy fulfillment inside one system. (cnbc.com) (usatoday.com) Amazon’s bet is that weight-loss drugs are becoming less of a specialty purchase and more of a standard pharmacy-and-primary-care service. The next test is whether lower friction on price, prescribing, and delivery brings more patients into treatment. (cnbc.com) (health.amazon.com)
